logo

Quick Facts

Share

Molson Coors Beverage Co. (TAP) announce Tuesday it has expanded its exclusive agreement with The Coca-Cola Co. (KO) to develop and commercialize a brand of full-flavor alcohol beverages inspired by the country's leading chilled juice brand, Simply. Molson Coors will produce, distribute and market...

Macellum Advisors GP, LLC, a long-term holder of nearly 5% of the outstanding common shares of Kohl's (KSS), urged Kohl's Board to publicly commit to carrying out a robust process to review strategic alternatives. Macellum advised the Board to form a special committee of independent directors to oversee...

Comtech Telecommunications Corp. (CMTL), a provider of next-generation 911 emergency systems and secure wireless communications technologies, announced Tuesday that the Company's Board of Directors has unanimously rejected the unsolicited proposal to acquire Comtech received from Acacia Research Corp....

Jack Henry & Associates, Inc. (JKHY) announced Tuesday that Chief Operating Officer Greg Adelson will become President and COO of the company, effective immediately. Adelson, who has been with the company for 11 years, has served as COO since 2019. As President and COO, Adelson will retain his current...

PACCAR (PCAR) reported fourth-quarter net profit of $511.4 million or $1.47 per share compared to $405.8 million or $1.17 per share, prior year. On average, 15 analysts polled by Thomson Reuters expected the company to report profit per share of $1.32, for the quarter. Analysts' estimates typically exclude...

Hess Corp. (HES) announced a 2022 Exploration & Production capital and exploratory budget of $2.6 billion, of which approximately 80% will be allocated to Guyana and the Bakken. Net production is projected to average between 330,000 and 340,000 barrels of oil equivalent per day in 2022, excluding Libya. Chief...

Chesapeake Energy Corporation (CHK) on Tuesday announced its decision to acquire Chief E&D Holdings and associated non-operated interests held by affiliates of Tug Hill, Inc. for $2 billion in cash and nearly 9.44 million shares. Chief and Tug Hill hold high quality producing assets and an inventory...

Mind Medicine (MindMed) Inc. (MNMD) said the FDA has cleared the company's Investigational New Drug application, allowing its phase 2b dose-optimization trial of MM-120 for the treatment of generalized anxiety disorder to proceed. The company said it is working with study investigators and clinical trial...

While reporting financial results for the fourth quarter on Tuesday, Lockheed Martin Corp. (LMT) provided its earnings, adjusted earnings and sales guidance for the full-year 2022. For fiscal 2022, the company now projects earnings of about $26.70 per share on net sales of about $66.00 billion. On...

Intersect ENT, Inc. (XENT) reported positive results of an observational, cohort study using real-world evidence data from adult patients with chronic rhinosinusitis with or without nasal polyps who underwent endoscopic sinus surgery. The company said the results showed that patients receiving PROPEL...

While reporting financial results for the fourth quarter and fiscal 2021 on Tuesday, Archer-Daniels-Midland (ADM) said it is optimistic for another very strong performance in 2022 as it progress towards its strategic plan's next earnings milestone of $6.00 to $7.00 per share. On average, 16 analysts...

American Express Company (AXP) said the company is increasing its aspiration to generate sustainable revenue and earnings growth over the long term with a new growth plan. Based on new growth plan and the benefits from an improving macro environment, the company projects elevated levels of revenue growth...

Pfizer Inc. (PFE) and BioNTech SE (BNTX) on Tuesday announced the initiation of a clinical trial to evaluate an Omicron-based vaccine candidate in adults 15 to 55 year of age. The study will have three cohorts examining different regimens of the current Pfizer-BioNTech COVID-19 vaccine or an Omicron-based...

Raytheon Technologies Corporation (RTX) said, for fiscal 2022, the company estimates: sales of $68.5 - $69.5 billion; adjusted EPS of $4.60 - $4.80; free cash flow of approximately $6.0 billion; and share repurchase of at least $2.5 billion of RTX shares. Analysts polled by Thomson Reuters expect the...

Johnson & Johnson (JNJ) said the company is well positioned for success in 2022 and beyond. For 2022, the company targets adjusted operational sales growth of 7.7% and adjusted operational EPS growth of 9.2%. For fiscal 2022, including COVID Vx, the company expects operational sales in a range of...

Follow RTT